1. Frick, K., et al., The cost of visual impairment: purposes, perspectives and guidance. Invest Ophthalmol Vis Sci, 2010. 51(4): p. 1801-1805.

2. The Eye Diseases Prevalence Research Group, Causes and prevalence of visual impairment among adults in the United States. Archives of Ophthalmology, 2004. 122: p. 477-485.

3. Friedman, D.S., et al., Vision problems in the U.S.: Prevalence of adult vision impairment and age-related eye disease in America, 2002, National Eye Institute (NEI): p. 36 pages.

4. U.S. Census Bureau and M.W. Brault, Americans with disabilities: 2005, household economic studies, U.S.D.o. Commerce, Editor 2008, U.S. Department of Commerce: Washington DC. p. P70-117.

5. US Census Bureau, Survey of Income and Program Participation, 2004.

6. Zhang, X., et al., Diabetes mellitus and visual impairment: national health and nutrition examination survey, 1999-2004. Arch Ophthalmol, 2008. 126(10): p. 1421-7.

7. Pascolini, D. and S. Mariotti, Global estimates of visual impairment: 2010. Br J Ophthalmol, 2012. 96(5): p. 614-8.

8. DeVol, R., et al. An Unhealthy America: The Economic Burden of Chronic Disease. 2007 4/23/2013]; Available from:

9. Taylor, H.R., M.L. Pezzullo, and J.E. Keeffe, The economic impact and cost of visual impairment in Australia. Br J Ophthalmol, 2006. 90(3): p. 272-5.

10. Rein, D.B., et al., The economic burden of major adult visual disorders in the United States. Arch Ophthalmol, 2006. 124(12): p. 1754-60.

11. Frick, K., et al., Economic impact of visual impairment and blindness in the United States. Arch Ophthalmol, 2007. 125: p. 544-550.

12. Access Economics, The Cost of Visual Impairment in the US, 2006, Access Economics Pty Lmt.

13. Gordois, A., et al., An estimation of the worldwide economic and health burden of visual impairment. Glob Public Health, 2012. 7(5): p. 465-81.

14. Resnikoff, S., et al., Global data on visual impairment in the year 2002. Bulletin of the World Health Organization, 2004. 82: p. 844–851.

15. WHO Department of Health Statistics and Informatics, World Health Statistics 2012, W.H.O. (WHO), Editor May 16, 2012: Geneva.

16. Rein, D.B., et al., The cost-effectiveness of Welcome to Medicare visual acuity screening and a possible alternative welcome to Medicare eye evaluation among persons without diagnosed diabetes mellitus. Arch Ophthalmol., 2012. 130(5): p. 607-14.

17. Ganz, M.L., Z. Xuan, and D.G. Hunter, Prevalence and correlates of children’s diagnosed eye and vision conditions. Ophthalmology, 2006. 113: p. 2298-2306.

18. Medical Expenditure Panel Survey (MEPS), Medical Expenditure Panel Survey pooled Agency for Healthcare Research and Quality, Editor 2003–2008, Agency for Healthcare Research and Quality: Rockville, MD.

19. Trogdon, J.G., E.A. Finkelstein, and T.J. Hoerger, Use of econometric models to estimate expenditure shares. Health Serv Res, 2008.

20. U.S. Census Bureau, P.D. Annual Estimates of the Population by Sex and Five-Year Age Groups for the United States: April 1, 2000 to July 1, 2006 (NC-EST2006-01). 2007 [cited 2008 11/21]; Available from:

21. Day, S., et al., Medicare costs for neovascular age-related macular degeneration, 1994-2007. Am J Ophthalmology, 2011. 152(6): p. 1014-20.

22. Schmier, J.K., et al., Medicare expenditures associated with diabetes and diabetic retinopathy. Retina, 2009. 29(2): p. 199-206.

23. Naser, N. and E.E. Hartmann. Comparison of state guidelines and policies for vision screening and eye exams: Preschool through early childhood. in Association for Research in Vision and Ophthalmology annual meeting. 2008.

24. Rein, D.B., et al., The potential cost-effectiveness of amblyopia screening programs. Journal of Pediatric Ophthalmology & Strabismus, 2012. 49(3): p. 146-155.

25. U.S. Bureau of Labor Statistics, M. Crawford, and J. Church. CPI detailed report. 2011 [cited 2011 September 14]; Available from:

26. U.S. Department of Education, Guide to U.S. Department of Education Programs, Fiscal Year 2010, O.o.C.a.O. U.S. Department of Education, Editor 2010, U.S. Department of Education: Washington DC.

27. Library of Congress, Library of Congress Fiscal 2011 Budget Justification, L.o. Congress, Editor 2011, Libary of Congress: Washington DC.

28. Brézin, A., et al., Prevalence and burden of self-reported blindness and low vision for individuals living in institutions: a nationwide survey. Health and Quality of Life Outcomes, 2005. 3(27).

29. Brézin, A., et al., Prevalence and burden of self-reported blindness, low vision, and visual impairment in the French community. Arch Ophthalmol., 2005. 123: p. 1117-1124.

30. Lafuma, A., et al., Evaluation of non-medical costs assoicated with visual impairment in four European countries: France, Italy, Germany and the UK. Pharmacoeconomics, 2006. 24(2): p. 193-205.

31. Lafuma, A., et al., Evaluation of Non-Medical Costs Associated with Visual Impairment in Four European Countries; Supplementary Material. Pharmacoeconomics, 2006. 24(2: Supplementary Material).

32. Wirth, K.E. and D.B. Rein, The economic costs and benefits of dog guides for the blind. Ophthalmic Epidemiol, 2008. 15(2): p. 92-8.

33. Apling, R.N., Individuals with Disabilities Education Act: Full Funding of State Formula, 2001, Congressional Research Service, The Library of Congress: Washington DC.

34. Chambers, J.G., T.B. Parrish, and J.J. Harr, What are we spending on special education services in the United States, 1999–2000?, 2004, Special Education Expenditure Project, Center for Special Education Finance.

35. U.S. Census Bureau, Statistical abstract of the United States, 2011, US Census Bureau, Editor 2011, US Census Bureau: Washington DC. p. 364.

36. Eslami, E., K. Filion, and M. Strayer, Characteristics of Supplemental Nutrition Assistance Program Households: Fiscal Year 2010, in U.S. Department of Agriculture, Food and Nutrition Service, Nutrition Assistance Program Report Series 2011, U.S. Department of Agriculture: Washington DC.

37. Social Security, A., Annual Statistical Report on the Social Security Disability Insurance Program, 2001: September 2002.

38. 111th Congress, Consolidated Appropriations Act, 2010, 2009, 111th Congress: Washington DC.

39. Internal Revenue Service, Publication 501 (2010), Exemptions, Standard Deduction, and Filing Information, I.R. Service, Editor 2011, Internal Revenue Service: Washington DC.

40. Gallaway, L. and R. Vedder, The impact of transfer payments on economic growth: John Stuart Mill versus Ludwig von Mises. The Quarterly Journal of Australian Economics, 2002. 5(1): p. 57-65.

41. Vedder, R. and L. Gallaway, Some underlying principles of tax policy, U.S.C. Joint Economic Committee Study, Editor 1998, Joint Economic Committee Study, United States Congress: Washington DC.

42. U.S. Bureau of Labor Statistics, American Time Use Survey—2010 Results, U.D.o. Labor, Editor 2011, US Department of Labor: Washington DC.

43. U.S. Bureau of Labor Statistics, Characteristics of minimum wage workers: 2010, U.D.o. Labor, Editor 2011, US Department of Labor: Washington DC.

44. Tielsch, J.M., et al., The prevalence of blindness and visual impairment among nursing home residents in Baltimore. New England Journal of Medicine, 1995. 332: p. 1205-1209.

45. Genworth Cost of Care Survey, Genworth 2013 Cost of Care Survey, 2013, Genworth Life Insurance Company: Richmond, VA.

46. Javitt, J.C., Z. Zhou, and R.J. Willke, Association between vision loss and higher medical care costs in Medicare beneficiaries costs are greater for those with progressive vision loss. Ophthalmology, 2007. 114(2): p. 238-245.

47. Salomon, J.A., et al., Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet, 2012. 380: p. 2129-43.

48. Jones, C., Comparing Treatments for Age-Related Macular Degeneration: Safety, Effectiveness and Cost. LDI Issues Brief, 2012. 17(8).

49. Bourne, R., H. Price, and G. Stevens, Global Burden of Visual Impairment and Blindness. Archives of Ophthalmology, 2012. 130(5).

50. Clemons, T.E., et al., National Eye Institute Visual Function Questionaire in the Age-Related Eye Disease Study (AREDS) AREDS Report No. 10. Archives of Ophthalmology, 2003. 121: p. 211-217.

51. Brown, M.L., J. Lipscomb, and C. Snyder, The Burden of Illness of Cancer: Economic Cost and Quality of Life. Annual Review of Public Health, 2001. 22: p. 91-113.

52. Brown, M.M., et al., Utility values associated with blindness in an adult population. British Journal of Ophthalmology, 2001. 85: p. 327-331.

53. Coffey Jt, B.M.Z.H.M.D.B.R.T.B.P.E.M.M.H.W.H., Valuing health-related quality of life in diabetes. Diabetes Care, 2002. 25(12): p. 2238-43.

54. Fryback, D.G., et al., The Beaver Dam Health Outcomes Study: Initial Catalog of Health-state Quality Factors. Medical Decision Making, 1993. 13: p. 89-102.

55. Mittmann, L., et al., Utility Scores for Chronic Conditions in a Community-Dwelling Population. Pharmacoeconomics, 1999. 15(4): p. 369-376.

56. Sharma, S., et al., Converting visual acuity to utilities. Canadian Journal of Ophthalmology, 2000. 35: p. 267-272.

57. Brown, M.M., et al., Quality of Life Associated with Visual Loss: A Time Tradeoff Utility Analysis Comparison with Medical Health States. Ophthalmology, 2003. 110: p. 1076-1081.

58. Brown, M.M., et al., Quality of life and systemic comorbidities in patients with ophthalmic disease. British Journal of Ophthalmology, 2002. 86: p. 8-11.

59. Crew, J.M., et al., Quality of life of the most severely vision-impaired. Clin Experiment Ophthalmol, 2011. 39(4): p. 336-43.

60. Brown, G.C., et al., Utility Values and Age-related Macular Degeneration. Archives of Ophthalmology, 2000. 118(47-51).

61. Chadha, R.K. and A. Subramanian, The effect of visual impairment on quality of life of children aged 3–16 years. British Journal of Ophthalmology, 2011. 95: p. 642-645.

62. Brown, M.M., et al., Health care economic analyses and value-based medicine. Survey of Ophthalmology, 2003. 48(2): p. 204-223.

63. Gold, M.R., et al., Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Medical Care, 1998. 36(6): p. 778-792.

64. Doubilet, P., et al., Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making, 1985. 5(2): p. 157-77.

65. Briggs, A., K. Claxton, and M. Schulpher, Decision modeling for health economic evaluation. 2006, New York: Oxford University Press.